“We'll hopefully have some AI-designed drugs in clinical trials by the end of the year. That's the plan.”

Demis HassabisCEO

CEO, Google DeepMind and Isomorphic Labs; 2024 Nobel laureate in Chemistry

Isomorphic Labs did not put any AI-designed drug into clinical trials during 2025. At Davos on 20 January 2026 Hassabis said the company now expects its first clinical trials by the end of 2026, which Reuters described as a delay to the original timeline.